Shukla Sath - Insider Non-Derivative Transactions at Spero Therapeutics, Inc. (SPRO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 27, 2024, Shukla Sath's relationship to Spero Therapeutics, Inc. (SPRO) is Officer (CEO & President), and currently has 1,140,809 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SPRO insiders.
Data Source: SEC.
Shukla Sath - Insider Non-Derivative Transactions of SPRO Common Stock
Shukla Sath - Insider Non-Derivative Transactions at SPRO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 28, 2024 | Sell -- (Common Stock) | 2757 | 1.35 | 1140809 |
| Aug 6, 2024 | Sell -- (Common Stock) | 17641 | 1.31 | 1143566 |
| Aug 3, 2024 | Sell -- (Common Stock) | 14800 | 1.32 | 1161207 |
| Feb 6, 2024 | Sell -- (Common Stock) | 45093 | 1.45 | 1176007 |
| Feb 3, 2024 | Sell -- (Common Stock) | 30901 | 1.37 | 1221100 |
| Feb 2, 2024 | Acquisition -- (Common Stock) | 679501 | 0 | 1252001 |
| Aug 30, 2023 | Sell -- (Common Stock) | 4163 | 1.3 | 572500 |
| Aug 29, 2023 | Sell -- (Common Stock) | 1854 | 1.26 | 576663 |
| Aug 2, 2023 | Acquisition -- (Common Stock) | 266000 | 0 | 578517 |
| Feb 3, 2023 | Sell -- (Common Stock) | 9504 | 1.83 | 312517 |
| Feb 2, 2023 | Acquisition -- (Common Stock) | 265957 | 0 | 322021 |